A Historic Change, an Unfinished Reckoning

AJWRB Official Statement

AJWRB’s response to the 2026 Jehovah’s Witness blood policy reforms: progress, accountability, and the continuing work of conscience

For Jehovah’s Witness readers and families: Read the statement addressed directly to you →

Summary

Conscience must be real, not merely announced

AJWRB has never argued that a competent adult should be compelled to accept transfusion. We defend the right of a properly informed adult with decision-making capacity to refuse treatment, even when others consider the decision unwise. But a life-and-death refusal is ethically valid only when it is informed, voluntary, and free from coercion. Private discussion with the patient is often essential to determining whether those conditions are present.

The Governing Body is free to teach what it believes is theologically correct. In AJWRB’s judgment, however, organizational authority should not be used to enforce a medical choice through mandated shunning, congregational sanctions, surveillance, or threats to a member’s closest family relationships.

Encouragingly, the September 18 guidance states that the congregation will not get involved in a member’s decision concerning components, that individual Christians should not judge one another, and that Hospital Liaison Committee (HLC) representatives will keep a patient’s decisions confidential.¹ Those protections now need to be communicated clearly and implemented consistently at every level, so that no Witness is investigated, pressured, stigmatized, or informally punished for exercising a newly recognized conscientious choice. Patients must have private opportunities to reconsider earlier directives and to state, product by product, what they presently accept or refuse.

Clinicians should neither assume that a Witness will refuse every blood product nor infer from the new policy what an individual patient will accept. They should explain relevant options in neutral language, assess decision-making capacity, and speak with the patient alone for at least part of the discussion. Older “No Blood” cards and advance directives should be examined respectfully, but they should not automatically be treated as proof of a current and informed refusal—an issue Douglas R. Migden and G. Richard Braen brought to the attention of emergency physicians as early as 1998.³

Unequal effects of the Jehovah’s Witness blood policy 2026 reform

The benefits of the new policy will not be distributed equally. A significant number of Jehovah’s Witnesses live in low-resource health systems where separated components, transfusion-medicine specialists, rapid transport, and advanced blood-conservation resources may not be reliably available.

The World Health Organization documents large income-related disparities in blood collection and component preparation.⁴ In those settings, a patient may now be religiously permitted to accept red cells, platelets, or plasma but arrive at a facility where the only promptly available transfusion product is whole blood. The policy did not create this infrastructure inequality, but the continuing whole-blood prohibition turns it into a differential religious burden.

Whole blood is also regaining an important role in well-resourced emergency systems. Paramedics and emergency medical technicians increasingly carry and administer blood products, including low-titer group O whole blood (LTOWB), before a patient reaches hospital. A 2025 National Association of EMS Physicians position statement identifies LTOWB as the first-choice product for eligible patients with life-threatening traumatic bleeding, and national data document growing demand for prehospital transfusion and substantial underuse among potentially eligible patients.⁵˒⁶ In catastrophic hemorrhage, the remaining prohibition may therefore govern treatment at the moment when delay is most dangerous.

An additional ambiguity arises because some LTOWB used in emergency care is leukocyte-reduced. Although transfusion medicine continues to classify such products as whole blood, leukoreduction deliberately removes most donor leukocytes, so the resulting product is not compositionally identical to the blood originally collected.⁷ This creates a potentially important uncertainty under the revised policy: red cells, white cells, platelets, and plasma are now individually matters of personal conscience, while whole blood remains prohibited.

Current Jehovah’s Witness guidance does not appear to explain how leukocyte-reduced LTOWB should be classified. The distinction may therefore create additional uncertainty for Witness patients, EMS personnel, and clinicians during time-critical treatment and reinforces the need for product-specific clarification of patient preferences.

AJWRB will continue to advocate for Witnesses in every country to have a genuinely free medical choice, and for that choice not to be constrained by religious sanctions or by avoidable inequality in access. The scale of this burden cannot responsibly be reduced to a single global percentage without country- and facility-level access data. It is enough, for present purposes, to recognize that the affected population is substantial and that the continuing prohibition will fall most heavily where medical options are already scarce.

The policy’s psychological afterlife

A formal reversal does not immediately undo decades of fear. Vaccination was condemned in Watchtower publications until 1952,⁸ and organ transplantation was described as cannibalistic from 1967 until returning to individual conscience in 1980.⁹ Some members remained reluctant after those restrictions ended. Blood may have an even longer psychological afterlife because the prohibition was taught for more than eight decades and linked to loyalty to God, everlasting life, and congregational standing.

Members may continue to experience fear, guilt, exaggerated perceptions of transfusion risk, or doubt that relatives and local elders will respect the new policy. Some may have internalized earlier warnings so deeply that the permitted option does not feel psychologically available. Bonnie Zieman describes this double bind as potentially involving spiritual condemnation and “social death.”¹⁰ Research by Windy Grendele, Savin Bapir-Tardy, and Maya Flax documents the coercive and psychological consequences of mandated shunning and recovery.¹¹,¹² These concerns bear directly on voluntariness and informed consent.

AJWRB will advocate for balanced reporting of transfusion’s benefits and risks. Transfusion is not risk-free, and responsible care includes patient blood management, careful thresholds, and clinically sound alternatives. But rare complications, historical risks, and restrictive transfusion practice should not be used to imply that indicated components are generally more dangerous than the severe anemia, hemorrhage, thrombocytopenia, or coagulopathy for which they are prescribed.

The reforms may also prompt grief, shame, guilt, anger, or moral injury among people who taught, defended, or applied the former rules. Responsibility is not equal; authority, knowledge, freedom to act, and direct involvement matter. Those struggling with these burdens should consider licensed mental-health care, particularly from professionals familiar with religious trauma, coercive control, shunning, or recovery from high-control environments. AJWRB support resources do not replace professional care or emergency services.

Children and adolescents: institutional choices with lasting consequences

AJWRB remains especially concerned for Jehovah’s Witness children and adolescents. They should not face avoidable death or serious disability because a parent applies a legacy rule or the continuing whole-blood prohibition. The concern is acute in leukemia and other blood disorders, where disease and intensive therapy can produce profound anemia, thrombocytopenia, and bleeding. Blood conservation should be used whenever clinically sound, but not as a euphemism for knowingly inferior care.

The historical record shows that resistance by children was cultivated through publications and congregation-based instruction. The May 22, 1994 Awake! presented young Witnesses who resisted transfusion as examples of faith and referred to youths dying while putting God first.¹³ A 1991 Watchtower article approvingly recounted a twelve-year-old’s stated intention to scream, struggle, remove the injecting device, and destroy a blood bag if transfusion were attempted.¹⁴ The September 1992 Our Kingdom Ministry instructed parents to prepare children for medical emergencies, rehearse encounters with physicians and judges, involve elders and HLC members early, and compare forced transfusion to sexual assault; a 1999 reminder again directed families to that material.¹⁵,¹⁶

These materials document sustained institutional preparation: children were presented with death in obedience as exemplary, coached for encounters with clinicians and courts, and taught to experience transfusion as a spiritual violation. Those choices warrant acknowledgment and accountability.

Parents ordinarily have wide authority to make medical decisions and transmit religious values, but that authority is not unlimited. Clinicians should determine whether a transfusion-free plan is genuinely equivalent to the best available care; seek the child’s or adolescent’s views while assessing maturity, voluntariness, and fear of family or congregational consequences; and involve pediatric, transfusion-medicine, ethics, social-work, and legal resources early. When refusal creates a material risk of preventable death or serious harm, child-protection or court authorization should be sought as required by the jurisdiction.

Clinicians and institutions also have moral agency. Where materially inferior care was accepted despite available standard treatment and foreseeable grave harm, they may share responsibility. Any judgment must remain case-specific and attentive to the law, evidence then available, urgency, and professional constraints.

Documenting the human cost

For decades, deaths associated with the blood prohibition have been debated without a comprehensive registry. Studies of patients who declined red-cell transfusion show increasing morbidity and mortality as hemoglobin falls, particularly at very low levels.¹⁷–¹⁹ More recent experience at a specialized blood-management center reports substantially lower absolute mortality with contemporary patient blood management, while still finding increasing composite morbidity or mortality as nadir hemoglobin declines.¹⁸ Guinn and colleagues extended the evidence beyond postoperative cohorts, finding increasing risks of death and myocardial ischemia as nadir hemoglobin declined among severely anemic hospitalized patients who refused transfusion.²⁰

AJWRB previously published a deliberately conservative mortality estimate. AJWRB-associated authors have now completed a global model of cumulative excess mortality associated with severe anemia managed without red-cell transfusion. The manuscript is being submitted to a medical journal, where its assumptions, inputs, uncertainty, evidentiary window, and limitations can undergo peer review; numerical findings will not be reproduced publicly before the authors authorize release. Our completed model suggests that the historical toll may be substantially greater than earlier estimates, while making uncertainty explicit rather than reducing individuals to a number.

The scale of the aftermath is difficult to describe without metaphor. A major natural disaster leaves lives lost, families altered, institutions strained, and years of triage, reconstruction, and reckoning. The blood policy has left an aftermath of comparable moral complexity, emotional trauma, disability, and death. But the analogy must stop there: this was not an act of nature. The harms arose within human institutions through decisions that were formulated, taught, enforced, defended, and repeatedly renewed. Repair will require more than changing a rule. It will require truth-telling, support for those who grieve, examination of professional and religious responsibility, and sustained work to prevent further harm.

Why sustained bioethical activism mattered

AJWRB was founded in 1997 by Lee Elder, then an active Jehovah’s Witness, as a forum for Witnesses to examine the blood policy and advocate for reform. Working with elders, HLC members, clinicians, researchers, and affected families, AJWRB argued that a refusal carrying risk of disability or death must rest on accurate medical and religious information and be free from coercion, surveillance, and fear of punishment. Elder remains AJWRB’s executive director.

The questions persisted for nearly three decades: Could refusal be voluntary when acceptance threatened family and congregation? Were patients receiving balanced information? Why were fractions permitted while the primary components from which they came were forbidden? What duties did clinicians have when institutional rules displaced individual judgment?

The 2026 reforms show that policy boundaries presented as divine requirements were subject to organizational revision. Rogers and Scully argue that sufficiently grave issues can create a duty to take a stand even when success seems unlikely, and call for case studies of such engagement.²¹ AJWRB’s experience illustrates how evidence-based activism can respect an adult’s right to refuse treatment while challenging conditions that make refusal less than free.

Activism also demands restraint: distinguishing evidence from inference, correcting errors, disclosing interests, welcoming criticism, avoiding claims of sole credit, and not speaking over those most affected. While the reasons for the Governing Body’s 2026 decisions have not been conclusively established from the available evidence, the historical record shows that, over the preceding decades, patients, dissenters, clinicians, scholars, editors, journalists, former members, organizations, online communities, and advocates kept the policy’s contradictions and consequences visible and preserved evidence. Their sustained role is noteworthy and deserves recognition.

“New light” and the limits of doctrinal revision

Among Jehovah’s Witnesses, “new light” describes progressive changes in doctrinal understanding and is associated in Watchtower publications with Proverbs 4:18.²² The expression also has historical resonance for AJWRB, which began in 1997 as the New Light on Blood initiative.

AJWRB does not regard the 2026 reforms as resolving the history of the blood policy. In important respects, they restore freedoms that existed before organizational leaders extended biblical blood prohibitions to medical transfusion. Charles Taze Russell did not treat the apostolic instruction to abstain from blood as a permanent medical prohibition, and Watchtower publications reported transfusions without condemnation before the prohibition emerged in the 1940s.²³

Religious organizations are free to revise their theology. The ethical question is what follows when an interpretation presented as a divine requirement is substantially revised after decades of enforcement and foreseeable harm. AJWRB has long argued that the transfusion prohibition reflected an organizational interpretation of biblical commands rather than an explicit biblical prohibition. Whatever theological explanation is offered now does not answer who made the earlier decisions, how they were enforced, or what consequences followed.

Some Witnesses find comfort in the hope of resurrection for those who died faithfully. That belief deserves respect, but it does not resolve the ethical and historical questions raised by preventable deaths under a policy later substantially revised, or eliminate the need to examine how that policy was formulated, taught, enforced, and maintained.

Moral and historical accountability

Many Witnesses who refused blood did so sincerely and courageously in accordance with what they believed God required. Recognizing organizational pressure and incomplete information does not deny their agency or disparage their faith. Nor does the reform prove that every past refusal was uninformed or involuntary.

Responsibility nevertheless extends beyond the individual patient. In AJWRB’s judgment, the former prohibition was a grave moral wrong: based on a contested interpretation of Scripture, ethically indefensible in its coercive enforcement, and maintained despite a foreseeable risk of preventable death and repeatedly documented mortality among patients declining transfusion. In biblical terms familiar to Witnesses, AJWRB believes the moral weight of preventable deaths may properly be described as bloodguilt. We use that term as a judgment about responsibility—not as a threat and not as a claim to know any person’s ultimate standing before God.

Historical attribution must be exact. The Dec 1, 1944 Watchtower explicitly applied the biblical prohibition on consuming blood to transfusion.²⁴ The Jul 1, 1945 article “Immovable for the Right Worship” then developed that position at length, and later Jehovah’s Witness historical accounts have identified the 1945 article with the establishment of the Christian requirement to abstain from blood transfusions.²⁵,²⁶ In Jan 15, 1961, The Watchtower made deliberate acceptance of transfusion grounds for expulsion if the member did not repent.²⁷ C. J. Woodworth and Frederick W. Franz were influential figures in the organization’s leadership and intellectual culture, but the publicly available primary record reviewed does not establish that either man was the sole author of the rule. AJWRB therefore assigns responsibility first to the institution and its decision-making leadership. Any more specific claim about individual authorship should await archival proof.

History will judge those who formulated, expanded, enforced, and defended the policy; later officials who, where the record shows they possessed both authority and relevant evidence, delayed reform; and, in different and case-specific measures, professionals and institutions that acquiesced in preventable harm. The form of accountability—historical, institutional, professional, legal where applicable, or personal—is not ours to determine. But a change of policy cannot erase the moral significance of what occurred.

Accountability should begin now with candor. The Governing Body should explain what changed and why; acknowledge the harm produced by the former rules; correct the record; apologize to affected patients and families; cooperate with lawful investigations and requests for relevant records; provide information where feasible to help establish the scope of serious injury and death associated with the former policy; protect rather than stigmatize those who raised concerns; and ensure that no member is punished formally or informally for exercising the newly recognized choices. A beneficial reform deserves welcome. An honest reform also requires truth about the past.

Acknowledging those who carried the work

AJWRB’s work and the wider advocacy surrounding the blood policy were sustained by medical expertise, historical research, ethical analysis, editing, technical and financial support, testimony, persistence, and moral courage. Some contributors acted publicly; others required anonymity because identification could cost family and community. Patients, families, current and former Witnesses, and anonymous sources who shared experiences and records are part of that foundation. These acknowledgments recognize contributions to AJWRB, the evidentiary record, or the broader debate; they do not attribute causation for the 2026 reforms, imply AJWRB affiliation, or suggest agreement with every AJWRB position.

Medical, scientific, bioethical, and mental-health contributors

AJWRB expresses profound gratitude to Dr. Osamu Muramoto, its medical adviser during the first five years. His pioneering scholarship brought dissenting Witness perspectives into the professional literature and helped shape AJWRB’s operating philosophy. At a formative stage, he steered AJWRB away from sensationalism and toward scholarly restraint, careful factual analysis, academic rigor, and established medical ethics. That influence continues to inform AJWRB’s research, writing, and epidemiological work.²⁸–³¹

We recognize Marvin Shilmer, AJWRB’s longtime science adviser, for decades of research and analysis; the late Dr. D. John Doyle, a distinguished anesthesiologist, engineer, bioethicist, medical adviser, and author; and the late Rosalie Hughes, one of AJWRB’s early editors.

We thank Bonnie Zieman, M.Ed., a retired licensed psychotherapist, for explaining psychological dynamics that can complicate blood-refusal decisions.¹⁰ We also recognize Dr. Windy Grendele, Dr. Savin Bapir-Tardy, and Maya Flax for peer-reviewed research on mandated shunning, psychological harm, and recovery, directly relevant to voluntariness and informed consent.¹¹,¹²

We also thank Dr. Reinhold Munker, Dr. Nickolas Davies, Daniel Graves, Faith McGinn, Garry Nichols, Tibor Nagy, Dr. John Holcomb, and Dr. Jon Krohmer, for clinical, scientific, legal, editorial, and organizational expertise.

Independent scholarship materially strengthened the evidence base. Douglas R. Migden, DO, JD, and G. Richard Braen, MD, examined the ethical and medicolegal adequacy of blood-refusal cards; Dr. Migden also corresponded with AJWRB. Jeffrey L. Carson, Helaine Noveck, Jesse A. Berlin, Steven A. Gould, Petra Seeber and colleagues, Aryeh Shander and colleagues, and Nicole R. Guinn, Mary L. Cooter, Claudia Villalpando, and Richard B. Weiskopf helped define the mortality and morbidity risks of severe anemia in patients declining transfusion.³,¹⁷–²⁰

Other research clarified specific clinical risks. Craig S. Kitchens reviewed surgical outcomes among Jehovah’s Witnesses; Andrei M. Beliaev, R. J. Marshall, M. Gordon, W. Smith, and J. A. Windsor evaluated allogeneic red-cell transfusion in severe symptomatic anaemia; and Sahana Gupta, Joseph Onwude, Roberto Stasi, and Isaac Manyonda identified gaps in UK obstetric and gynaecological management of Witness women.³²–³⁴

AJWRB members and organizational supporters

We thank Dieter Parczany, AJWRB executive-committee member and former HLC chairman in Berlin, as well as the original group of eight HLC members who participated in the very early days of AJWRB. They are honored collectively and still require anonymity.

We thank Wayne Rogers, AJWRB’s first public-relations representative; John Mitchell, a former Bethel elder who assisted with editing; and the late Raymond Franz, a former Governing Body member whose research, experience, writings, counsel, and encouragement supplied important historical context.

We are grateful to Richard Kelly, Lee Marsh, and John Hoyle for leadership and practical support through AAWA from 2012 onward, and to AJWRB members Mark O’Donnell, Dianne Hancherow, Javier Ortiz, John Meulenberg, Kelly Bryan, Richard DeZubeldia, Zack Daniels, David Claus, and Kerry Louderback-Wood, along with many others whose varied contributions included research, writing, legal analysis, editing, advocacy, support, and institutional memory. Louderback-Wood’s article examined potential liability arising from representations about the blood policy.³⁵

Independent writers, researchers, advocates, and communities

Among independent contributors, we acknowledge Doug Mason; Jerry R. Bergman; M. James (“Jim”) Penton; David Reed; Ken Raines; Randy Watters; Lloyd Evans; Chaka Yumba; Joni Valkila; John Whedbee; Paul Grundy; Jason Wynne; and Scott Douglas Jacobsen. Bergman wrote on Jehovah’s Witnesses and blood transfusion, Penton situated the doctrine within the movement’s history, and Raines documented Watchtower medical-policy history.³⁶–³⁸

We also acknowledge the National Secular Society for examining NHS relationships with HLCs and raising patient-autonomy concerns in the United Kingdom, and Sam Carling MP for bringing related concerns before the House of Commons and calling for review of NHS trust policies toward HLC involvement.³⁹,⁴⁰

We recognize Steven Hassan and Jon Atack for wider work on undue influence and authoritarian control,⁴¹ and Rosie Luther, Heather J. Ransom, Rebecca L. Monk, Adam Qureshi, and Derek Heim for empirical research on shunning, identity transition, social loss, and recovery among former Jehovah’s Witnesses.⁴²,⁴³

We thank Simon, founder and administrator of Jehovahs-Witness.com, whose forum enabled early online debate among Witness elders, HLC members, former members, and others examining the blood prohibition. We also recognize moderators and contributors of the ex-Jehovah’s Witness Reddit community for preserving documents, sharing experiences, testing arguments, and providing support when formal channels were closed.

This list remains incomplete. We also recognize the clinicians, lawyers, legislators, researchers, former elders, volunteers, translators, donors, correspondents, patients, families, and anonymous sources whose work may never be publicly credited.

Journals that opened the debate

AJWRB offers particular thanks to the Journal of Medical Ethics. Under Professor Raanan Gillon’s editorship, it provided a rigorous forum for examining, defending, and criticizing the policy. Gillon addressed dissenting Witness views and physicians’ responsibility to ensure patients understood that refusal was not regarded as religiously required by all Witnesses.⁴⁴ The journal also published Lee Elder’s 2000 article, written on behalf of AJWRB members, presenting the theological and ethical case of Witnesses who accepted blood while rejecting official policy.⁴⁵

The debate also included substantive defenses of the official Jehovah’s Witness position. David Malyon defended transfusion-free treatment in terms of patient autonomy and religious conviction, while D. T. Ridley disputed Muramoto’s claims about organizational pressure, confidentiality, and individual conscience.⁴⁶,⁴⁷

We thank the Western Journal of Medicine for publishing Muramoto’s 1999 review and the BMJ for publishing his 2001 analysis.³⁰,³¹ The BMJ also preserved rapid responses that became an early sustained public exchange among AJWRB participants, clinicians, readers, and defenders of the official Jehovah’s Witness position.⁴⁸

The work ahead

The reform materially advances individual conscience, but AJWRB’s work is not finished. The whole-blood prohibition remains; its burden falls heavily on patients in health systems where components are unavailable. Legacy advance directives and institutional materials require review. Members need accurate risk information and private opportunities to reconsider choices formed under the former policy. Children and adolescents still require protection when parental religious commitments conflict with life-saving or harm-preventing care.

AJWRB will continue to:

• support evidence-based patient blood management and appropriate blood conservation;
• defend access to clinically indicated transfusion and the best available care;
• respect the right of a properly informed adult with decision-making capacity to refuse treatment;
• oppose religious coercion, mandated shunning, and congregational sanctions connected to medical choice;
• advocate for children, adolescents, and patients constrained by dependency or unequal access;
• document the policy’s history and human consequences with transparent methods; and
• press for full institutional acknowledgment, correction, and accountability.

For an adult with decision-making capacity, the medical decision belongs to the patient. It should not be displaced by a religious organization, local congregation, family member, clinician, or advocacy group. For children and patients who lack decision-making capacity, decisions should be made under applicable legal and ethical standards, with protection from coercive institutional influence.

AJWRB welcomes the progress that has occurred. We mourn those for whom it came too late. We thank those who made the questions impossible to ignore. We call for honesty about the policy’s human cost and accountability for its consequences. And we remain committed to a future in which every Jehovah’s Witness can receive accurate information and exercise medical choice free from coercion, fear, or punishment, consistent with age and decision-making capacity.

References

1. Jehovah’s Witnesses. Each Witness Now Decides Whether to Accept or Donate Main Blood Components. JW.org; Sep 18, 2026. See also: How Do Jehovah’s Witnesses Show Respect for Life? JW.org. Accessed Sep 23, 2026.
2. Governing Body of Jehovah’s Witnesses. 2026 Governing Body Update #2. JW.org; Mar 20, 2026.
3. Migden DR, Braen GR. The Jehovah’s Witness blood refusal card: ethical and medicolegal considerations for emergency physicians. Acad Emerg Med. 1998;5(8):815–824.
4. World Health Organization. Global status report on blood safety and availability 2025. Geneva: WHO; 2026.
5. Brown JB, et al. Prehospital Trauma Compendium: Transfusion of Blood Products in Trauma—A Position Statement and Resource Document of NAEMSP. Prehosp Emerg Care. 2025:1–10.
6. Carico C, Annesi C, Mann NC, et al. Nationwide trends in prehospital blood product use after injury, 2020–2023. Transfusion. 2025;65(Suppl 1):S30–S39.
7. American Red Cross. Low Titer O Whole Blood. American Red Cross. Accessed Sep 25, 2026.
8. Elder L. The Watchtower vaccination ban unveiled, 1921–1952. AJWRB; 2026.
9. Elder L. Jehovah’s Witnesses and organ transplants: the forgotten medical reversal. AJWRB; 2026.
10. Zieman B. When belief meets survival: understanding the psychological dynamics of Jehovah’s Witness blood refusal. AJWRB; Aug 7, 2025.
11. Grendele WA, Bapir-Tardy S, Flax M. Experiencing religious shunning: insights into the journey from being a member to leaving the Jehovah’s Witnesses community. Pastoral Psychol. 2024;73:43–61.
12. Grendele WA, Bapir-Tardy S, Flax M. Coping after shunning: experiences of former Jehovah’s Witnesses in the United Kingdom. Pastoral Psychol. 2026. doi:10.1007/s11089-026-01333-8.
13. Watch Tower Bible and Tract Society. Youths Who Put God First. Awake! May 22, 1994:2–15.
14. Watch Tower Bible and Tract Society. Questions From Readers. The Watchtower. Jun 15, 1991:30–31.
15. Watch Tower Bible and Tract Society. Safeguarding Your Children From Misuse of Blood. Our Kingdom Ministry. September 1992:3–6.
16. Watch Tower Bible and Tract Society. Question Box: Are You Prepared for an Emergency? Our Kingdom Ministry. September 1999:7.
17. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion. 2002;42(7):812–818.
18. Seeber P, Trentino KM, Murray K, Lucas M. A further update on mortality and morbidity in patients with very low hemoglobin levels who decline blood transfusion. Transfusion. 2024;64(7):1198–1206. doi:10.1111/trf.17867.
19. Shander A, Javidroozi M, Naqvi S, et al. An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion. Transfusion. 2014;54(10 Pt 2):2688–2695.
20. Guinn NR, Cooter ML, Villalpando C, Weiskopf RB. Severe anemia associated with increased risk of death and myocardial ischemia in patients declining blood transfusion. Transfusion. 2018;58(10):2290–2296.
21. Rogers WA, Scully JL. Activism and bioethics: taking a stand on things that matter. Hastings Cent Rep. 2021;51(4):32–33.
22. Jehovah’s Witnesses. Why Have Jehovah’s Witnesses Changed Some of Their Beliefs? JW.org. Accessed Sep 23, 2026.
23. Elder L. Blood transfusion in modern history. AJWRB; 2026.
24. Watch Tower Bible and Tract Society. The Stranger’s Right Maintained. The Watchtower. 1944;65(23):355–367, esp. 362.
25. Watch Tower Bible and Tract Society. Immovable for the Right Worship. The Watchtower. 1945;66(13):195–203, esp. 198–201.
26. Watch Tower Bible and Tract Society. Part 3—United States of America. 1975 Yearbook of Jehovah’s Witnesses, discussing the Jul 1, 1945 Watchtower adoption of the transfusion rule.
27. Watch Tower Bible and Tract Society. Questions From Readers. The Watchtower. Jan 15, 1961:63–64.
28. Muramoto O. Bioethics of the refusal of blood by Jehovah’s Witnesses: part 1. J Med Ethics. 1998;24(4):223–230.
29. Muramoto O. Bioethics of the refusal of blood by Jehovah’s Witnesses: part 2. J Med Ethics. 1998;24(5):295–301.
30. Muramoto O. Recent developments in medical care of Jehovah’s Witnesses. West J Med. 1999;170(5):297–301.
31. Muramoto O. Bioethical aspects of the recent changes in the policy of refusal of blood by Jehovah’s Witnesses. BMJ. 2001;322(7277):37–39.
32. Kitchens CS. Are transfusions overrated? Surgical outcome of Jehovah’s Witnesses. Am J Med. 1993;94(2):117–119.
33. Beliaev AM, Marshall RJ, Gordon M, Smith W, Windsor JA. Clinical benefits and cost-effectiveness of allogeneic red-blood-cell transfusion in severe symptomatic anaemia. Vox Sang. 2012;103(1):18–24.
34. Gupta S, Onwude J, Stasi R, Manyonda I. Refusal of blood transfusion by Jehovah’s Witness women: a survey of current management in obstetric and gynaecological practice in the U.K. Blood Transfus. 2012;10(4):462–470.
35. Louderback-Wood K. Jehovah’s Witnesses, blood transfusions, and the tort of misrepresentation. J Church State. 2005;47(4):783–822.
36. Bergman JR. Jehovah’s Witness and blood transfusions. Journal of Biblical Counseling. 1980;4(2).
37. Raines K. The Watchtower Society and medical quackery. JW Research Journal. Fall 1996:3–8; revised July 2021.
38. Penton MJ. Apocalypse Delayed: The Story of Jehovah’s Witnesses. 3rd ed. Toronto: University of Toronto Press; 2015.
39. National Secular Society. Rethink relations with Jehovah’s Witnesses committees, NSS urges NHS. National Secular Society; Sep 24, 2020.
40. UK Parliament. Small Religious Organisations: Safeguarding. Hansard, House of Commons; Mar 2, 2026.
41. Hassan SA, Atack J. Assessment of potential harm in Eastern religions: the Influence Continuum and the BITE Model of Authoritarian Control. In: Moffic HS, Gogineni RR, Peteet JR, et al, eds. Eastern Religions, Spirituality, and Psychiatry. Cham: Springer; 2024:325–335.
42. Luther R. What happens to those who exit Jehovah’s Witnesses: an investigation of the impact of shunning. Pastoral Psychol. 2023;72(1):105–120.
43. Ransom HJ, Monk RL, Qureshi A, Heim D. Life after social death: leaving the Jehovah’s Witnesses, identity transition and recovery. Pastoral Psychol. 2021;70:53–69.
44. Gillon R. Refusal of potentially life-saving blood transfusions by Jehovah’s Witnesses: should doctors explain that not all JWs think it’s religiously required? J Med Ethics. 2000;26(5):299–301. doi:10.1136/jme.26.5.299.
45. Elder L. Why some Jehovah’s Witnesses accept blood and conscientiously reject official Watchtower Society blood policy. J Med Ethics. 2000;26(5):375–380. doi:10.1136/jme.26.5.375.
46. Malyon D. Transfusion-free treatment of Jehovah’s Witnesses: respecting the autonomous patient’s rights. J Med Ethics. 1998;24(5):302–307. doi:10.1136/jme.24.5.302.
47. Ridley DT. Jehovah’s Witnesses’ refusal of blood: obedience to scripture and religious conscience. J Med Ethics. 1999;25(6):469–472. doi:10.1136/jme.25.6.469.
48. BMJ. Rapid responses to Muramoto O, “Bioethical aspects of the recent changes in the policy of refusal of blood by Jehovah’s Witnesses.” Online responses to BMJ. 2001;322:37–39. Accessed Sep 23, 2026.